{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:11:20Z","timestamp":1794557480817,"version":"4.9.1"},"reference-count":213,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":592,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1P30AG066506-01"],"award-info":[{"award-number":["1P30AG066506-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13311-022-01185-z","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:27:47Z","timestamp":1643282867000},"page":"8-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials"],"prefix":"10.1016","volume":"19","author":[{"given":"Ranjan","family":"Duara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-7142","authenticated-orcid":false,"given":"Warren","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","article-title":"Multiple pathologies are common and related to dementia in the oldest-old: the 90+ Study","volume":"85","author":"Kawas","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01185-z_bib3","doi-asserted-by":"crossref","unstructured":"Komarova NL, Thalhauser CJ. High degree of heterogeneity in Alzheimer's disease progression patterns. PLoS Comput Biol. 2011;7(11):e1002251.","DOI":"10.1371\/journal.pcbi.1002251"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1007\/s13311-022-01185-z_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/CON.0000000000000700","article-title":"Late-onset Alzheimer disease","volume":"25","author":"Rabinovici","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1007\/s13311-022-01185-z_bib7","doi-asserted-by":"crossref","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, et al. Dominantly inherited Alzheimer network. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253\u201360.","DOI":"10.1212\/WNL.0000000000000596"},{"issue":"23","key":"10.1007\/s13311-022-01185-z_bib8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/tpj.2009.58","article-title":"ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease","volume":"10","author":"Stone","year":"2010","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib10","doi-asserted-by":"crossref","first-page":"e12007","DOI":"10.1002\/trc2.12007","article-title":"Effect of apolipoprotein E \u03b54 allele on the progression of cognitive decline in the early stage of Alzheimer's disease","volume":"6","author":"Suzuki","year":"2020","journal-title":"Alzheimers Dement (N Y)."},{"issue":"16","key":"10.1007\/s13311-022-01185-z_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta-analysis consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1007\/s13311-022-01185-z_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.mp.4001262","article-title":"Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype","volume":"8","author":"Sweet","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/JGP.0b013e3181e446c8","article-title":"Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the Cardiovascular Health Study","volume":"19","author":"Emanuel","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317516679303","article-title":"Association of GWAS top genes with late-onset Alzheimer's disease in Colombian population","volume":"32","author":"Moreno","year":"2017","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1176\/appi.ajp.2012.11121815","article-title":"Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study","volume":"169","author":"Sweet","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-022-01185-z_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.exger.2017.10.020","article-title":"Hidden heterogeneity in Alzheimer's disease: insights from genetic association studies and other analyses","volume":"107","author":"Yashin","year":"2018","journal-title":"Exp Gerontol"},{"issue":"40","key":"10.1007\/s13311-022-01185-z_bib17","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-\u03b2 alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","article-title":"Changes in A\u03b2 biomarkers and associations with APOE genotype in 2 longitudinal cohorts","volume":"36","author":"Resnick","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","article-title":"The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration","volume":"1801","author":"Koldamova","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"89","key":"10.1007\/s13311-022-01185-z_bib21","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med."},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib22","doi-asserted-by":"crossref","first-page":"556.e513","DOI":"10.1016\/j.neurobiolaging.2010.10.020","article-title":"Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease","volume":"32","author":"Bekris","year":"2011","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.1007\/s13311-022-01185-z_bib23","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamaneurol.2014.1491","article-title":"Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study","volume":"71","author":"Naj","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12017-012-8217-7","article-title":"Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population","volume":"15","author":"Ma","year":"2013","journal-title":"Neuromolecular Med"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1474-9726.2011.00705.x","article-title":"Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited","volume":"10","author":"Deelen","year":"2011","journal-title":"Aging Cell"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib26","first-page":"1401","article-title":"Replication of genome-wide association study findings of longevity in White, African American, and Hispanic women: the Women's Health Initiative","volume":"72","author":"Shadyab","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib28","doi-asserted-by":"crossref","first-page":"e53830","DOI":"10.1371\/journal.pone.0053830","article-title":"Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis","volume":"8","author":"Holliday","year":"2013","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1007\/s13311-022-01185-z_bib29","first-page":"S439","article-title":"Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study","volume":"33","author":"Weinstein","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-022-01185-z_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The cardiovascular health study: design and rationale","volume":"1","author":"Fried","year":"1991","journal-title":"Ann Epidemiol"},{"key":"10.1007\/s13311-022-01185-z_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ije\/dyu067","article-title":"Cohort profile: the Health and Retirement Study (HRS)","volume":"43","author":"Sonnega","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1007\/s13311-022-01185-z_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.exger.2017.10.020","article-title":"Hidden heterogeneity in Alzheimer's disease: insights from genetic association studies and other analyses","volume":"107","author":"Yashin","year":"2018","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2008-13407","article-title":"Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism","volume":"13","author":"Urosevic","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-022-01185-z_bib34","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399411002006","article-title":"Emerging roles of pathogens in Alzheimer disease","volume":"13","author":"Miklossy","year":"2011","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3233\/JAD-160607","article-title":"Herpes and Alzheimer's disease: subversion in the central nervous system and how it might be halted","volume":"54","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer's disease","volume":"51","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"De Chiara","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-022-01185-z_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4933-7-16","article-title":"Alzheimer's disease gene signature says: beware of brain viral infections","volume":"7","author":"Porcellini","year":"2010","journal-title":"Immun Ageing"},{"issue":"12","key":"10.1007\/s13311-022-01185-z_bib39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","article-title":"A comprehensive genetic association study of Alzheimer disease in African Americans","volume":"68","author":"Logue","year":"2011","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib40","doi-asserted-by":"crossref","first-page":"e87017","DOI":"10.1371\/journal.pone.0087017","article-title":"Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib41","doi-asserted-by":"crossref","first-page":"936.e935","DOI":"10.1016\/j.neurobiolaging.2013.09.025","article-title":"Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population","volume":"35","author":"Omoumi","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-150580","article-title":"Shared genetic etiology between type 2 diabetes and Alzheimer's disease identified by bioinformatics analysis","volume":"50","author":"Gao","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1007\/s13311-022-01185-z_bib43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.exger.2008.03.010","article-title":"Apolipoprotein E, an important player in longevity and age-related diseases","volume":"43","author":"Ang","year":"2008","journal-title":"Exp Gerontol"},{"issue":"6\u20137","key":"10.1007\/s13311-022-01185-z_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.mad.2011.06.008","article-title":"A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals","volume":"132","author":"Nebel","year":"2011","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib45","doi-asserted-by":"crossref","first-page":"e99580","DOI":"10.1371\/journal.pone.0099580","article-title":"Genetic variants in PVRL2-TOMM40-APOE region are associated with human longevity in a Han Chinese population","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01185-z_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exger.2014.02.004","article-title":"ApoE gene and exceptional longevity: insights from three independent cohorts","volume":"53","author":"Garatachea","year":"2014","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2014.1605","article-title":"The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis","volume":"18","author":"Garatachea","year":"2015","journal-title":"Rejuvenation Res"},{"issue":"16","key":"10.1007\/s13311-022-01185-z_bib48","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/hmg\/ddu139","article-title":"Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age","volume":"23","author":"Deelen","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jhg.2015.150","article-title":"Association of common variants in TOMM40\/APOE\/APOC1 region with human longevity in a Chinese population","volume":"61","author":"Lin","year":"2016","journal-title":"J Hum Genet"},{"issue":"7307","key":"10.1007\/s13311-022-01185-z_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1194\/jlr.R075697","article-title":"ApoE and lipid homeostasis in Alzheimer's disease: introduction to the thematic review series","volume":"58","author":"Chang","year":"2017","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib52","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1038\/tp.2014.89","article-title":"Are APOE varepsilon genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?","volume":"4","author":"Lyall","year":"2014","journal-title":"Transl Psychiatry"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/gerona\/glq028","article-title":"A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium","volume":"65","author":"Newman","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib54","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1194\/jlr.R075408","article-title":"The role of APOE on lipid homeostasis and inflammation in normal brains","volume":"58","author":"Rebeck","year":"2017","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib55","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/carcin\/bgi088","article-title":"Associations between apoE genotype and colon and rectal cancer","volume":"26","author":"Slattery","year":"2005","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20020329","article-title":"Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis","volume":"104","author":"Watson","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1007\/s13311-022-01185-z_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","article-title":"Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease","volume":"15","author":"El-Lebedy","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1007\/s13311-022-01185-z_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1358\/dot.2006.42.7.973588","article-title":"Links between Alzheimer's disease and diabetes","volume":"42","author":"Sun","year":"2006","journal-title":"Drugs Today (Barc)"},{"issue":"7","key":"10.1007\/s13311-022-01185-z_bib59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10072-014-1797-2","article-title":"Diabetes and the brain: issues and unmet needs","volume":"35","author":"Bornstein","year":"2014","journal-title":"Neurol Sci"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/138161211795164239","article-title":"Genome-wide association studies: is there a genotype for cognitive decline in older persons with type 2 diabetes?","volume":"17","author":"Abbatecola","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib61","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4239\/wjd.v5.i6.889","article-title":"Type 2 diabetes mellitus and Alzheimer's disease","volume":"5","author":"Barbagallo","year":"2014","journal-title":"World J Diabetes"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib62","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1007\/s13311-022-01185-z_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/18715273113126660134","article-title":"Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies","volume":"13","author":"Dai","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1 Suppl","key":"10.1007\/s13311-022-01185-z_bib65","first-page":"S26","article-title":"How does brain insulin resistance develop in Alzheimer's disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/18715273113126660135","article-title":"Molecular linkages between diabetes and Alzheimer's disease: current scenario and future prospects","volume":"13","author":"Dar","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10522-015-9618-4","article-title":"Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease","volume":"17","author":"Grimm","year":"2016","journal-title":"Biogerontology"},{"key":"10.1007\/s13311-022-01185-z_bib69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.12659\/MSM.895622","article-title":"Associations between genetic variants in 19p13 and 19q13 regions and susceptibility to Alzheimer disease: a meta-analysis","volume":"22","author":"Bao","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1007\/s13311-022-01185-z_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.24999","article-title":"Polygenic risk score analysis of pathologically confirmed Alzheimer disease","volume":"82","author":"Escott-Price","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01185-z_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002258","article-title":"Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score","volume":"14","author":"Desikan","year":"2017","journal-title":"PLoS Med"},{"key":"10.1007\/s13311-022-01185-z_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-160889","article-title":"The correlation between inflammatory biomarkers and polygenic risk score in Alzheimer's disease","volume":"56","author":"Morgan","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-022-01185-z_bib74","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jalz.2015.02.013","article-title":"A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid A\u03b242","volume":"11","author":"Sleegers","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"214","key":"10.1007\/s13311-022-01185-z_bib75","first-page":"e7","article-title":"Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease","volume":"49","author":"Escott-Price","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-022-01185-z_bib76","doi-asserted-by":"crossref","first-page":"36955","DOI":"10.18632\/oncotarget.6271","article-title":"Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population","volume":"6","author":"Xiao","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/brain\/awz384","article-title":"A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap","volume":"143","author":"Badhwar","year":"2020","journal-title":"Brain"},{"issue":"7","key":"10.1007\/s13311-022-01185-z_bib78","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1007\/s12035-015-9388-7","article-title":"Multiple effect of APOE genotype on clinical and neuroimaging biomarkers across Alzheimer's disease spectrum","volume":"53","author":"Liu","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib79","doi-asserted-by":"crossref","first-page":"e54483","DOI":"10.1371\/journal.pone.0054483","article-title":"Dissecting the gene dose-effects of the APOE \u03b54 and \u03b52 alleles on hippocampal volumes in aging and Alzheimer's disease","volume":"8","author":"Hostage","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11481-016-9722-5","article-title":"Safety and efficacy of anti-amyloid-\u03b2 immunotherapy in Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Penninkilampi","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-022-01185-z_bib82","doi-asserted-by":"crossref","unstructured":"Salloway S, Chalkias S, Barkhof F, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2021;e214161.","DOI":"10.1001\/jamaneurol.2021.4161"},{"issue":"24","key":"10.1007\/s13311-022-01185-z_bib83","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01185-z_bib84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alz Res Therapy"},{"key":"10.1007\/s13311-022-01185-z_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-022-01185-z_bib86","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank","volume":"16","author":"Barker","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s13311-022-01185-z_bib88","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01185-z_bib89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","article-title":"Vulnerable neural systems and the borderland of brain aging and neurodegeneration","volume":"77","author":"Jagust","year":"2013","journal-title":"Neuron"},{"key":"10.1007\/s13311-022-01185-z_bib90","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnagi.2013.00050","article-title":"Relation of neuropathology with cognitive decline among older persons without dementia","volume":"5","author":"Boyle","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib91","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnen\/nlz126","article-title":"Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations","volume":"79","author":"Besser","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology-concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","article-title":"Non-Alzheimer's contributions to dementia and cognitive resilience in the 90+ Study","volume":"136","author":"Robinson","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib94","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-013-1170-1","article-title":"Reply: the early pathological process in sporadic Alzheimer's disease","volume":"126","author":"Braak","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"Pt 4","key":"10.1007\/s13311-022-01185-z_bib96","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer's disease features distinct structures of amyloid-\u03b2","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib97","doi-asserted-by":"crossref","first-page":"E782","DOI":"10.1073\/pnas.1714966115","article-title":"Structural heterogeneity and intersubject variability of A\u03b2 in familial and sporadic Alzheimer's disease","volume":"115","author":"Condello","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib98","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib99","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jalz.2016.09.015","article-title":"Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample","volume":"13","author":"Brenowitz","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"Pt 3","key":"10.1007\/s13311-022-01185-z_bib100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/brain\/awl385","article-title":"Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease","volume":"130","author":"Reed","year":"2007","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01185-z_bib101","doi-asserted-by":"crossref","unstructured":"2020 Alzheimer's disease facts and figures. Alzheimer's Dement. 2020;16:391\u2010460.","DOI":"10.1002\/alz.12068"},{"issue":"19","key":"10.1007\/s13311-022-01185-z_bib102","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Ch\u00eane","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib104","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/WNL.49.6.1498","article-title":"Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study","volume":"49","author":"Seshadri","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/aje\/153.2.132","article-title":"Is the risk of developing Alzheimer's disease greater for women than for men?","volume":"153","author":"Hebert","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib106","doi-asserted-by":"crossref","first-page":"e210169","DOI":"10.1001\/jamanetworkopen.2021.0169","article-title":"Sex differences in cognitive decline among US adults","volume":"4","author":"Levine","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib107","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jalz.2018.08.003","article-title":"Sex and gender in Alzheimer's disease - does it matter?","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/WAD.0000000000000187","article-title":"Time, sex, gender, history, and dementia","volume":"31","author":"Rocca","year":"2017","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib109","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jalz.2018.12.013","article-title":"Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort","volume":"15","author":"Santos","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00401-018-1908-x","article-title":"Sex and age interact to determine clinicopathologic differences in Alzheimer's disease","volume":"136","author":"Liesinger","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib111","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5","article-title":"Rates of dementia in three ethnoracial groups","volume":"14","author":"Gurland","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1007\/s13311-022-01185-z_bib112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1532-5415.2003.51054.x","article-title":"Prevalence of dementia in older Latinos: the influence of type2 diabetes mellitus, stroke and genetic factors","volume":"51","author":"Haan","year":"2003","journal-title":"Jam Geriatr Soc"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib113","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jalz.2009.04.1234","article-title":"Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and Whites","volume":"5","author":"Potter","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib114","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jamda.2010.07.010","article-title":"Prevalence of health conditions and predictors of mortality in oldest old Mexican Americans and non-Hispanic Whites","volume":"13","author":"Samper-Ternent","year":"2012","journal-title":"J Am Med Dir Assn"},{"issue":"12","key":"10.1007\/s13311-022-01185-z_bib115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jalz.2019.08.202","article-title":"Prevalence and correlates of mild cognitive impairment among diverse Hispanics\/Latinos: study of Latinos-investigation of neurocognitive aging results","volume":"15","author":"Gonz\u00e1lez","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jalz.2016.06.2360","article-title":"Systematic review of dementia prevalence and incidence in United States race\/ethnic populations","volume":"13","author":"Mehta","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib117","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/WNL.49.1.44","article-title":"Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees","volume":"49","author":"Perkins","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1532-5415.2001.49096.x","article-title":"Dementia and race: are there differences between African Americans and Caucasians?","volume":"49","author":"Froehlich","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/EDE.0000000000000747","article-title":"Cognitive aging in Black and White Americans: cognition, cognitive decline, and incidence of Alzheimer disease dementia","volume":"29","author":"Weuve","year":"2018","journal-title":"Epidemiology"},{"issue":"14","key":"10.1007\/s13311-022-01185-z_bib120","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2013.2973","article-title":"Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E epsilon 4, and the risk of late-onset Alzheimer disease in African Americans","volume":"309","author":"Reitz","year":"2013","journal-title":"JAMA"},{"key":"10.1007\/s13311-022-01185-z_bib121","doi-asserted-by":"crossref","first-page":"f7051","DOI":"10.1136\/bmj.f7051","article-title":"Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study","volume":"347","author":"Yaffe","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WAD.0b013e318211c6c9","article-title":"Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease","volume":"25","author":"Chin","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib123","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11065-008-9064-z","article-title":"Lifecourse social conditions and racial and ethnic patterns of cognitive aging","volume":"18","author":"Glymour","year":"2008","journal-title":"Neuropsychol Rev"},{"key":"10.1007\/s13311-022-01185-z_bib124","series-title":"Racial and ethnic disparities among individuals with Alzheimer's disease in the United States: a literature review","first-page":"248","author":"Lines","year":"2014"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0022146516645925","article-title":"Life course pathways to racial disparities in cognitive impairment among older Americans","volume":"57","author":"Zhang","year":"2016","journal-title":"J Health Soc Behav"},{"issue":"12","key":"10.1007\/s13311-022-01185-z_bib126","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1212\/01.WNL.0000147473.04043.B3","article-title":"Social resources and cognitive decline in a population of older African Americans and Whites","volume":"63","author":"Barnes","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13607863.2015.1081152","article-title":"Social participation predicts cognitive functioning in aging adults over time: comparisons with physical health, depression, and physical activity","volume":"21","author":"Bourassa","year":"2017","journal-title":"Aging Ment Health"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1088868314523839","article-title":"Depression and social identity: an integrative review","volume":"18","author":"Cruwys","year":"2014","journal-title":"Pers Soc Psychol Rev"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib129","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/ijerph15102315","article-title":"Effects of participation in social activities on cognitive function among middle-aged and older adults in Korea","volume":"15","author":"Hwang","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib130","doi-asserted-by":"crossref","first-page":"igaa015","DOI":"10.1093\/geroni\/igaa015","article-title":"Pathways from social activities to cognitive functioning: the role of physical activity and mental health","volume":"4","author":"Cohn-Schwartz","year":"2020","journal-title":"Innov Aging"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib131","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1017\/S1355617711000531","article-title":"Late-life social activity and cognitive decline in old age","volume":"17","author":"James","year":"2011","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1007\/s13311-022-01185-z_bib132","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-016-0201-2","article-title":"Older patients are still under-represented in clinical trials of Alzheimer's disease","volume":"8","author":"Banzi","year":"2016","journal-title":"Alzheimers Res Ther."},{"key":"10.1007\/s13311-022-01185-z_bib133","doi-asserted-by":"crossref","unstructured":"Anderson TS, Ayanian JZ, Souza J, Landon BE. Representativeness of participants eligible to be enrolled in clinical trials of aducanumab for Alzheimer disease compared with medicare beneficiaries with Alzheimer disease and mild cognitive impairment. JAMA. 2021:e2115286.","DOI":"10.1001\/jama.2021.15286"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib134","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2125.2012.04423.x","article-title":"Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials","volume":"75","author":"Rollin-Sillaire","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40520-018-1087-6","article-title":"Factors influencing attrition in 35 Alzheimer's disease centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's uniform data set","volume":"31","author":"Burke","year":"2019","journal-title":"Aging Clin Exp Res"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib136","doi-asserted-by":"crossref","first-page":"e42325","DOI":"10.1371\/journal.pone.0042325","article-title":"Rates of decline in Alzheimer disease decrease with age","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1007\/s13311-022-01185-z_bib137","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.0000000000001376","article-title":"Differences in Alzheimer disease clinical trial outcomes based on age of the participants","volume":"84","author":"Schneider","year":"2015","journal-title":"Neurology"},{"issue":"228","key":"10.1007\/s13311-022-01185-z_bib138","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med."},{"key":"10.1007\/s13311-022-01185-z_bib139","first-page":"10","article-title":"Influence of cognitive reserve on cognitive trajectories: role of brain pathologies","volume":"7","author":"Li","year":"2021","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1007\/s13311-022-01185-z_bib140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/geront\/gnr043","article-title":"Introduction to the science of recruitment and retention among ethnically diverse populations","volume":"51","author":"Dilworth-Anderson","year":"2011","journal-title":"Gerontologist"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib141","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.wad.0000190803.11340.66","article-title":"Recruitment strategies for studying dementia in later life among diverse cultural groups","volume":"19","author":"Dilworth-Anderson","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s13311-022-01185-z_bib142","unstructured":"New IDEAS: imaging dementia-evidence for amyloid scanning study, study protocol, 2020. ClinicalTrials.gov identifier: NCT04426539. Updated December 31, 2021. Accessed December 25, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04426539"},{"key":"10.1007\/s13311-022-01185-z_bib143","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1007\/s13311-022-01185-z_bib144","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fnagi.2017.00309","article-title":"Classifying MCI subtypes in community-dwelling elderly using cross-sectional and longitudinal MRI-based biomarkers","volume":"9","author":"Guan","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.neurobiolaging.2010.05.020","article-title":"Alzheimer's pathology in primary progressive aphasia","volume":"33","author":"Rohrer","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"3\u20134","key":"10.1007\/s13311-022-01185-z_bib146","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504341","article-title":"Neurodegenerative patterns of cognitive clusters of early-onset Alzheimer's disease subjects: evidence for disease heterogeneity","volume":"48","author":"Phillips","year":"2019","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"19","key":"10.1007\/s13311-022-01185-z_bib147","doi-asserted-by":"crossref","first-page":"e2414","DOI":"10.1212\/WNL.0000000000011883","article-title":"Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer disease","volume":"96","author":"Qian","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","article-title":"Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome","volume":"5","author":"Lam","year":"2013","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib149","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/JAD-140261","article-title":"Subgroups of Alzheimer's disease: stability of empirical clusters over time","volume":"42","author":"Peter","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nrl.2015.08.002","article-title":"Early- and late-onset Alzheimer disease: are they the same entity?. Enfermedad de Alzheimer de inicio precoz y de inicio tard\u00edo: \u00bfson la misma entidad?","volume":"33","author":"Tellechea","year":"2018","journal-title":"Neurologia (Engl Ed)."},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib151","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","article-title":"Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE \u025b4 allele","volume":"10","author":"van der Flier","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-022-01185-z_bib152","doi-asserted-by":"crossref","unstructured":"Ye BS, Seo SW, Lee Y, et al. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study. Dement Geriatr Cogn Disord. 2012;34.","DOI":"10.1159\/000342973"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib153","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1533317512454711","article-title":"Nonamnestic presentations of early-onset Alzheimer's disease","volume":"27","author":"Mendez","year":"2012","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib154","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002093-199809000-00007","article-title":"Age at onset and visuocognitive disturbances in Alzheimer disease","volume":"12","author":"Fujimori","year":"1998","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s13311-022-01185-z_bib155","series-title":"Handbook of assessment in clinical gerontology","first-page":"529","article-title":"Functional assessment of the older adult patient","author":"Loewenstein","year":"1999"},{"issue":"11","key":"10.1007\/s13311-022-01185-z_bib156","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/gerona\/glu155","article-title":"The motor signature of mild cognitive impairment: results from the gait and brain study","volume":"69","author":"Montero-Odasso","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"10.1007\/s13311-022-01185-z_bib157","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01185-z_bib158","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-022-01185-z_bib159","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: a concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J Intern Med"},{"issue":"15","key":"10.1007\/s13311-022-01185-z_bib161","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1007\/s13311-022-01185-z_bib162","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1474-4422(17)30332-0","article-title":"24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial","volume":"16","author":"Soininen","year":"2017","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1007\/s13311-022-01185-z_bib163","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib164","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S1041610217001879","article-title":"Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease","volume":"30","author":"Siafarikas","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1007\/s13311-022-01185-z_bib165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000381800","article-title":"Relationship between dementia severity and behavioral and psychological symptoms of dementia in Alzheimer's disease patients","volume":"5","author":"Hashimoto","year":"2015","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-190025","article-title":"Neuropsychiatric symptoms and risk of progression to Alzheimer's disease among mild cognitive impairment subjects","volume":"70","author":"Dietlin","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib167","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study","volume":"172","author":"Peters","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-022-01185-z_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.718949","article-title":"Neuropsychiatric profile as a predictor of cognitive decline in mild cognitive impairment","author":"Roberto","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-022-01185-z_bib169","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.archger.2016.04.006","article-title":"Neuropsychiatric symptoms and apolipoprotein E: associations with eventual Alzheimer's disease development","volume":"65","author":"Burke","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"10.1007\/s13311-022-01185-z_bib170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.0000000000001307","article-title":"Neuropsychiatric symptoms, APOE \u03b54, and the risk of incident dementia. A population-based study","volume":"84","author":"Pink","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-022-01185-z_bib171","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","article-title":"Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels","volume":"24","author":"Babulal","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib172","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/awaa058","article-title":"Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease","volume":"143","author":"Tetreault","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib173","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment","volume":"12","author":"Ismail","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-022-01185-z_bib174","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-201184","article-title":"Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline","volume":"80","author":"Ismail","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib176","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41398-021-01675-2","article-title":"Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology","volume":"11","author":"Sun","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-022-01185-z_bib177","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/s41598-021-83126-y","article-title":"Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis","volume":"11","author":"Roberto","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib178","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp.2006.100529","article-title":"Cerebrospinal fluid beta-amyloid 1\u201342 concentration may predict cognitive decline in older women","volume":"78","author":"Gustafson","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib179","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2012.07.004","article-title":"A\u03b2 amyloid, cognition, and APOE genotype in healthy older adults","volume":"9","author":"Lim","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib181","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-022-01185-z_bib182","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","article-title":"Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis","volume":"128","author":"Qu","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib183","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jnnp-2013-306285","article-title":"An algorithmic approach to structural imaging in dementia","volume":"85","author":"Harper","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1007\/s13311-022-01185-z_bib184","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.55.4.484","article-title":"Rates of hippocampus atrophy correlate with change status in aging and AD","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","article-title":"Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study","volume":"11","author":"Whitwell","year":"2012","journal-title":"Lancet Neurol"},{"issue":"21","key":"10.1007\/s13311-022-01185-z_bib186","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","article-title":"Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline","volume":"89","author":"Risacher","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib187","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","article-title":"Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease","volume":"77","author":"Al-Shaikh","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib188","doi-asserted-by":"crossref","first-page":"e0186595","DOI":"10.1371\/journal.pone.0186595","article-title":"MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis","volume":"12","author":"Persson","year":"2017","journal-title":"PLoS ONE"},{"issue":"Pt 9","key":"10.1007\/s13311-022-01185-z_bib189","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01185-z_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference","volume":"9","author":"Young","year":"2018","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-022-01185-z_bib191","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fneur.2019.00524","article-title":"Subtypes of Alzheimer's disease display distinct network abnormalities extending beyond their pattern of brain atrophy","volume":"10","author":"Ferreira","year":"2019","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-022-01185-z_bib192","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.dadm.2017.03.007","article-title":"Resting-state network dysfunction in Alzheimer's disease: a systematic review and meta-analysis","volume":"8","author":"Badhwar","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1007\/s13311-022-01185-z_bib193","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fnagi.2020.00272","article-title":"Bridging the gap between fluid biomarkers for Alzheimer's disease, model systems, and patients","volume":"12","author":"Bjorkli","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-022-01185-z_bib194","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jalz.2018.05.006","article-title":"Special topic section: responses to the NIA-AA research framework","volume":"15","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1007\/s13311-022-01185-z_bib195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol"},{"issue":"23","key":"10.1007\/s13311-022-01185-z_bib196","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"JAMA"},{"issue":"19","key":"10.1007\/s13311-022-01185-z_bib197","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib198","first-page":"e12104","article-title":"Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia","volume":"12","author":"Shen","year":"2020","journal-title":"Alzheimers Dement (Amst)."},{"key":"10.1007\/s13311-022-01185-z_bib199","doi-asserted-by":"crossref","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, et al. Head-to-Head Comparison of 8 Plasma Amyloid-\u03b2 42\/40 Assays in Alzheimer Disease. JAMA Neurol. 2021;78(11):1375-1382.","DOI":"10.1001\/jamaneurol.2021.3180"},{"issue":"2","key":"10.1007\/s13311-022-01185-z_bib200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib201","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jalz.2018.08.005","article-title":"Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's Disease Neuroimaging Initiative","volume":"15","author":"Veitch","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"8000","key":"10.1007\/s13311-022-01185-z_bib202","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"5580","key":"10.1007\/s13311-022-01185-z_bib203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"8","key":"10.1007\/s13311-022-01185-z_bib204","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"De Meyer","year":"2010","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1007\/s13311-022-01185-z_bib205","doi-asserted-by":"crossref","first-page":"e47739","DOI":"10.1371\/journal.pone.0047739","article-title":"Enrichment and stratification for predementia Alzheimer disease clinical trials","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1007\/s13311-022-01185-z_bib206","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/brain\/awaa088","article-title":"Microglial activation and tau burden predict cognitive decline in Alzheimer's disease","volume":"143","author":"Malpetti","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13195-021-00880-x","article-title":"Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals","volume":"13","author":"Biel","year":"2021","journal-title":"Alzheimers Res Ther."},{"issue":"18","key":"10.1007\/s13311-022-01185-z_bib208","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1007\/s13311-022-01185-z_bib209","doi-asserted-by":"crossref","first-page":"e2673","DOI":"10.1212\/WNL.0000000000012022","article-title":"Finding treatment effects in Alzheimer trials in the face of disease progression heterogeneity","volume":"96","author":"Jutten","year":"2021","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01185-z_bib210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.dadm.2018.06.007","article-title":"Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers","volume":"10","author":"Goyal","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JAD-190230","article-title":"Disentangling heterogeneity in Alzheimer's disease: two empirically-derived subtypes","volume":"70","author":"Blanken","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s13311-022-01185-z_bib212","doi-asserted-by":"crossref","first-page":"e200413","DOI":"10.1001\/jamanetworkopen.2020.0413","article-title":"Distilling heterogeneity of mild cognitive impairment in the National Alzheimer Coordinating Center Database using latent profile analysis","volume":"3","author":"Blanken","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1007\/s13311-022-01185-z_bib213","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13195-018-0455-y","article-title":"Heterogeneity of Alzheimer's disease: consequence for drug trials?","volume":"10","author":"Devi","year":"2018","journal-title":"Alzheimers Res Ther"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01185-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:24Z","timestamp":1761806304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":213,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1878747923001514"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01185-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01185-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}